Canada PsyCan aims to be ‘go-to’ psychedelics industry organization, receives support from lawmakers The non-profit trade association received a high level of interest from multiple branches of government Rowan DunneNovember 10, 2022
Canada PsyCan pushes federal policy-makers to lift restrictions on psychedelics Non-profit says Canada needs to make room for healthcare innovation with respect to psychedelic therapies Rowan DunneSeptember 21, 2022
International PharmAla Biotech to provide University of Sydney with LaNeo MDMA for clinical studies Organization to supply GMP product for second major clinical trial down under this month Rowan DunneAugust 31, 2022
Canada PharmAla Biotech applies for patent on 6 novel MDMA-like molecules Application follows successful pre-clinical animal studies at the University of Arkansas Rowan DunneAugust 29, 2022
Canada PharmAla Biotech becomes first public company producing GMP MDMA Biotechnology organization will also supply LaNeo product to Australian research institute for clinical trial Rowan DunneAugust 22, 2022
Canada PharmAla Biotech initiates MDMA supplier agreement with InterVivo Biotechnology company will supply InterVivo and clients with clinical-grade MDMA for scientific analyses Rowan DunneAugust 5, 2022